Skip to main content

Animations

MJFF Publications

4811 - 4820 of 6422 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Genome sequence analyses identify novel risk loci for multiple system atrophy
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuron.2024.04.002
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Subcellular proteomics of dopamine neurons in the mouse brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.70921
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.75253
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-240213
    Citation Count: 3
  • Summary Details
    OPEN
    Title: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes15091185
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30019
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson’s Disease
    Journal Name: Tremor and Other Hyperkinetic Movements
    Publisher: Ubiquity Press, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.5334/tohm.552
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson's Disease
    Journal Name: Journal of Clinical Neurology
    Publisher: Korean Neurological Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3988/jcn.2019.15.1.102
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.